IN8bio (INAB) CFO McCall received 250,000 units
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Patrick McCall (Chief Financial Officer at IN8bio Inc., INAB) reported that they received 250,000 units on Sep 4, 2024.
- Reporting person
- McCall Patrick
- Role
- CHIEF FINANCIAL OFFICER
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 4, 2024 | Grant or award (A) | Employee Stock Option (right to buy)On 250,000 Common Stock1 | +250,000 | - | - | 250,000 direct |
Holdings before and after
- Employee Stock Option (right to buy): 0 to 250,000 direct
Footnotes from the filing
- 1. Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did McCall report in this INAB Form 4?
Patrick McCall (Chief Financial Officer at IN8bio Inc., INAB) reported that they received 250,000 units on Sep 4, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for INAB
Earlier insider filings at INAB
- Sep 5, 2024SEC Form 4 filed by PRESIDENT AND CEO Ho William Tai-Wei
- Sep 5, 2024SEC Form 4 filed by Chief Medical Officer Goswami Trishna
- Sep 5, 2024SEC Form 4 filed by EVP and CSO Lamb Lawrence
- Jun 14, 2024SEC Form 4 filed by Director Whitfill Travis
- Jun 14, 2024SEC Form 4 filed by Director Greenwood Luba
Keep researching INAB
- INAB insider tradesEvery buy and sale reported by IN8bio Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- INAB earnings historyPast IN8bio Inc. earnings releases, newest first.
- INAB financial statementsRevenue, profit, cash flow and balance sheet from IN8bio Inc.'s SEC filings.
Quantisnow market dataNASDAQ
INAB
IN8bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for INAB
Full INAB profile on Quantisnow Follow INAB and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time